Indian Pharma Units Face Closure Over GMP Non-Compliance
DCGI directs state authorities to enforce strict GMP compliance by December 31, 2025. Delhi, Himachal Pradesh, Uttarakhand already taking action against non-compliant manufacturers.
Category : Search result: smallcap pharma stock
DCGI Orders Global Pharma Standards Implementation by Jan 2026
India's drug regulator DCGI mandates global manufacturing standards for all pharma companies by January 2026. State regulators ordered to begin inspections immediately. Read about the strict compliance requirements.
Sun Pharma: US Tariff Clarity & Q2 FY26 Outlook
Sun Pharma investors await Q2 FY26 results with cautious optimism as US tariff clarity emerges. Discover how import duties and market dynamics could impact India's pharmaceutical giant.
Multibagger Stock Rallies 1750% in 5 Years
Discover how Waaree Renewables Technologies became a multibagger sensation, delivering staggering returns while defying broader market trends. Learn why this renewable energy stock continues to attract investor attention.
Indian Pharma Soars with Record US Generic Drug Profits
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
AstraZeneca Q3 Profit Jumps 77% to $2.53 Billion
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Piramal Pharma Bets on US Biopharma Funding Revival
Piramal Pharma anticipates significant growth as US biopharma funding shows recovery signs, with CDMO business poised for major expansion.
Small-Cap IT Stock Jumps 30% in 3 Sessions
Discover why this undervalued small-cap IT stock is creating massive buzz with 30% gains in just three trading sessions. Expert analysis reveals whether this rally has legs or if it's just market hype.
Solara Pharma Q2 Loss: ₹10 Crore Amid Challenges
Solara Active Pharma Sciences faces challenging quarter with ₹10 crore net loss despite revenue growth. Discover the operational challenges and management's recovery strategy.
Sun Pharma Q2 Profit Rises 2.5% to ₹3,118 Crore
India's pharmaceutical giant Sun Pharma reports steady Q2 growth with 9% revenue increase while navigating US market challenges. Key insights from their latest earnings report.
Navin Fluorine Shares Surge 22% in 3 Sessions
Discover why Navin Fluorine International shares skyrocketed 22% in just three trading sessions. Expert analysis reveals the key drivers behind this chemical sector powerhouse's impressive rally and what investors should watch next.
Q2 Results Today: Sun Pharma, Grasim, Britannia Earnings
Market eyes Wednesday's Q2 earnings bonanza as pharma giant Sun Pharma, Grasim Industries, and FMCG major Britannia declare results. Get complete analysis and investor expectations.
Krishival Foods Stock Soars 400% in 5 Years
Discover how Krishival Foods became a stock market sensation with explosive 400% returns. This FMCG multibagger is inching closer to its 52-week high, creating massive wealth for investors. Learn why analysts are bullish on this rising star.
CoLab Platforms: 19,500% Returns in 5 Years
Discover how CoLab Platforms became India's latest stock market phenomenon with unprecedented 19,500% returns over five years and 96 consecutive upper circuits, creating massive wealth for investors.
3 Hot Stocks: Grasim, Aurobindo Pharma, City Union Bank
Religare Broking's Ajit Mishra reveals 3 promising stocks for short-term gains. Discover technical analysis and price targets for Grasim, Aurobindo Pharma, and City Union Bank in this exclusive market insight.
Small-Cap Stock Soars 8% in Dalal Street Trend Reversal
A small-cap stock defies market odds with an impressive 8% surge following a significant trend reversal pattern on Dalal Street. Technical analysis reveals strong bullish signals as trading volume spikes.
Multibagger Stock Soars 1,100% in One Year
Discover how Waaree Renewables Technologies delivered staggering 1,100% returns in just 12 months, hitting upper circuits repeatedly. Learn what's driving this solar energy stock's phenomenal performance.
Hot Stocks: Oil India, Aurobindo Pharma, Latent View Analysis
Get expert stock market insights from Jigar Patel of Anand Rathi as he reveals why Oil India, Aurobindo Pharma, and Latent View Analytics present compelling short-term opportunities for Indian investors.
Multibagger Stock Soars 1350%, Declares Dividend & Q2 Results
Discover how a small-cap multibagger stock delivered staggering 1350% returns year-to-date as it prepares to declare Q2 FY2025 results and interim dividend. Board meeting date revealed!
3 Stocks Under ₹200: Expert Picks for Growth
Discover three high-potential stocks trading below ₹200 that could deliver strong returns. Expert analysis from Mehul Kothari of Anand Rathi reveals hidden gems in today's volatile market.
RR Kabel Q2: ₹4 Dividend, Record Date Nov 28
RR Kabel delivers strong Q2 FY2025 performance with impressive revenue growth and operating profit. The smallcap gem announces ₹4 per share interim dividend - check key financial highlights and record date details.
Health Biotech Expands Global Presence at CPhI Frankfurt
Indian biopharmaceutical leader Health Biotech Limited makes waves at CPhI Frankfurt 2025, showcasing innovative products and forging international partnerships to strengthen its global market position.
Niner Pharma Expands R&D with 125 New Peptide Molecules
Chandigarh-based Niner Pharma announces massive R&D expansion with 125 novel peptide molecules targeting wellness and cosmetic innovation, positioning India as global leader in peptide research.
Small-Cap Multibagger Jumps 7% After 94% Profit Surge
Discover how this small-cap multibagger stock delivered explosive Q2 FY2025 results with 94% profit surge and 39% revenue growth, triggering massive investor interest.
Small-cap stock soars 600% in 5 years - under ₹50!
Discover how a little-known small-cap stock under ₹50 delivered staggering 600% returns in just five years and why analysts are watching it closely now.
Cipla Shares Fall 4% After Q2 Results
Cipla's stock faced significant pressure after Q2 FY2025 results revealed margin pressures despite revenue growth. Discover the key factors behind the 4% decline and what analysts are saying about the pharmaceutical giant's future prospects.
US Push for Affordable Biotech Drugs: India's Opportunity
Federal health officials are accelerating efforts to bring cheaper biotech drugs to market, potentially transforming treatment access and creating new opportunities for Indian pharmaceutical companies.
India Bans Fraudulent Pharma Licenses in Major Reform
India implements sweeping regulatory reforms to combat fraudulent pharmaceutical manufacturing licenses, enhancing drug safety standards for domestic and international markets including US and EU.
Smallcap star defers rights issue after 100% returns
Discover why a high-performing smallcap company postponed its rights issue despite delivering 100% returns to shareholders. Technical reasons cited for the delay.
Krishival Foods Stock Soars 97% in 2024
Krishival Foods shares continue their spectacular rally, hitting fresh record highs and delivering massive returns to shareholders. Discover why this smallcap stock is making waves in the Indian stock market.
Page 3 of 4